The women’s health market continues to see unprecedented competition for transactions, write attorneys with McGuireWoods. These trends, along with COVID-19-specific transaction considerations, create interesting dynamics for investors and providers in the women’s health and fertility subsectors, as discussed during a webinar, “Key Transaction and Regulatory Considerations for Women’s Health and Fertility,” presented by McGuireWoods healthcare lawyers Kayla Marty and Erin Dine. Read more.
Related Posts
North Carolina Bill Would Carve UNC Hospitals Out of Antitrust Laws
North Carolina's state Senate passed a bill this week that would exempt the UNC Health Care system from federal and state antitrust laws.
May 3, 2023
AHA, Hospital Groups File Court Brief Asking to Restore ACA Preventive Services Mandate
The medical associations said preventive health services are essential to increase longevity and quality of life and that medical evidence should dictate preventive care recommendations rather than political considerations.
May 15, 2023
Change Healthcare Said to Want Reverse Breakup Fee from UnitedHealth Ahead of Antitrust Trial
The Change Healthcare board is talking about a potential reverse fee of more than 5%. The original merger agreement didn't include a reverse termination fee.
March 24, 2022
Surprise-Billing Legislation Took Away Envision Healthcare’s ‘Secret Sauce,’ Economist Says
The No Surprises Act officially went into effect on Jan. 1, 2022, but before then, creditors already could see Envision would likely struggle to pay back its massive debts. This eventually led to Envision filing for chapter 11 bankruptcy protection in May, hoping to wipe out $5.6 billion in obligations.
June 20, 2023